Display Tender HPVITS2019-058.003
This page displays the details of a tender.
Contacts
- Robert Luong
- Office: +61 (03) 9947 3933
- r.luong@healthsharevic.org.au
Agency: HealthShare Victoria
Type of work: Goods & Services
Type: Request for Tender
Title: HPVITS2019-058.003 – Pharmaceutical Products and IV Fluids Supplementary 003
RFx Number: HPVITS2019-058.003
Description:
Notice of upcoming tender:
HPVITS2019-058.003 – Pharmaceutical Products and IV Fluids Supplementary 003
Scope:
| Subcategory number | Subcategory name |
|
517.01 |
Arsenic trioxide 10mg/10mL injection, ampoule/vial,10mL |
|
83001.01 |
Bevacizumab 100mg/4mL injection, ampoule/vial, 4mL |
|
83001.02 |
Bevacizumab 400mg/16mL injection, ampoule/vial, 16mL |
|
518.01 |
Bortezomib injection, ampoule/vial |
|
519.01 |
Cabazitaxel 60mg injection, ampoule/vial |
|
527.01 |
Carmustine 100mg injection, ampoule/vial |
|
520.01 |
Daptomycin 350mg injection, ampoule/vial |
|
520.02 |
Daptomycin 500mg injection, ampoule/vial |
|
521.01 |
Deferasirox 90mg tablet/capsule 30 |
|
521.02 |
Deferasirox 180mg tablet/capsule 30 |
|
521.03 |
Deferasirox 360mg tablet/capsule 30 |
|
522.01 |
Desflurane 1mL/1mL or 1g/1g Inhalation solution, bottle 250mL |
|
197.03 |
Furosemide (Frusemide) 20mg/2mL injection, ampoule/vial, 2mL |
|
523.01 |
Imatinib 100mg tablet/capsule 30 (GIST indication) |
|
523.02 |
Imatinib 100mg tablet/capsule 30 (non-GIST indication) |
|
523.03 |
Imatinib 400mg tablet/capsule 60 (GIST indication) |
|
523.04 |
Imatinib 400mg tablet/capsule 60 (non-GIST indication) |
|
524.01 |
Methylprednisolone (sodium succinate) 500mg injection, ampoule/vial |
|
524.02 |
Methylprednisolone (sodium succinate) 1g injection, ampoule/vial |
|
325.02 |
Moxifloxacin 400mg tablet/capsule 5 |
|
525.01 |
Oseltamivir 30mg capsule 10 |
|
525.02 |
Oseltamivir 45mg capsule 10 |
|
525.03 |
Oseltamivir 75mg capsule 10 |
|
526.01 |
Sodium nitroprusside 50mg/2mL injection, ampoule/vial, 2mL |
|
499.04 |
Vancomycin 500mg injection, ampoule/vial |
Market Release Date: 01 March 2021
All enquiries regarding this supplementary tender prior to the market release date should be directed to r.luong@healthsharevic.org.au or (03)99473933 . Once the tender has been released, please direct all correspondence through the HSV Procurement Portal.